Primary Recommendation

CentralNic - 44% eps accretive deal

December 2019

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

“Few major corporations in North America have had the success that Verisign (VRSN; Nasdaq) has achieved, with its share price up five-fold in seven years.” That’s a direct quote from Ben Crawford, chief executive of CentralNIC, who I met last month. Many UK investors might not have heard of Verisign. At the heart of its business is its ownership of the infrastructure for a portfolio of “top-level domains,” which today include .com, .net, .tv, .edu, and .gov (a TLD is simply the name for the group of letters to the right of the dot in your website or email address).An engineer culture devised and developed the networking technology that has made the modern internet possible. When the intern ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Volex - High growth and exciting

Softcat - 56 quarters of consecutive organic growth

CentralNIC (May 2023)

CentralNic (January 2023)

CentralNic (October 2022)

CentralNic (March 2022)

CentralNIC (February 2022)

CentralNic - Year-to-date organic growth now reaching a record 29%; 268p broker target (November 2021)

CentralNic (October 2021)

CentralNic (July 2021)

CentralNic (February 2021)

CentralNIC (January 2021)

CentralNIC - 20% eps accretive acquisition of Codewise (October 2020)

CentralNic (April 2020)

CentralNic (February 2020)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X